Yun Chen

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

Jing Huang, Jianming Xu, Yun Chen et al. · The Lancet Oncology · 2020 · 568 citations

Esophageal Cancer, Gastrointestinal Oncology, Medicine +10

Development of a Porcine Bladder Acellular Matrix with Well-Preserved Extracellular Bioactive Factors for Tissue Engineering

Bin Yang, Yifen Zhang, Liuhua Zhou et al. · Tissue Engineering Part C Methods · 2010 · 205 citations

Tissue Engineering, Engineering, Cell Culture +19

Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations

Jiaying Deng, Hu Chen, Daizhan Zhou et al. · Nature Communications · 2017 · 127 citations · Full text

Engineering, Esophageal Cancer, Genetics +16

Patterns of distant organ metastases in esophageal cancer: a population-based study

Dashan Ai, Hanting Zhu, Wenjia Ren et al. · Journal of Thoracic Disease · 2017 · 114 citations · Full text

Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial

Qi Liu, Junqiang Chen, Lin Yu et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 65 citations

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +8